PRECONDITIONING MESENCHYMAL STEM CELLS WITH TRANSFORMING GROWTH FACTOR-ALPHA IMPROVES MESENCHYMAL STEM CELL-MEDIATED CARDIOPROTECTION

Jeremy L. Herrmann, Yue Wang, Aaron M. Abarbanell, +3

Shock

Bone Marrow MscsCardiac MuscleCell TherapyAdult Stem CellImmunology +14

VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function

Troy A. Markel, Yue Wang, Jeremy L. Herrmann, +7

American Journal of Physiology-Heart and Circulatory Physiology

Adult Stem CellCell ProliferationOrgan IschemiaBiomedical EngineeringCrucial Paracrine Factor +19

Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p

Huaner Ni, Weifeng Li, Ying Zhuge, +5

International Journal of Cardiology

InflammationFibrosisMolecular PhysiologyCardiovascular DiseaseCardiovascular Pharmacology +10

Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B

Guo‐Hua Qiu, Xiaojin Xie, Fang Xu, +3

Cytotechnology

HepatologyDistinctive Pharmacological DifferencesLiver PhysiologyPathologyHepatotoxicity +7

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

Demin Cheng, Qi Xu, Yue Wang, +7

Journal of Translational Medicine

Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration

Wenjuan Pu, Hui Zhang, Xiuzhen Huang, +17

Nature Communications

Confirmatory Tests for the Diagnosis of Primary Aldosteronism

Ying Song, Shumin Yang, Wenwen He, +13

Hypertension

Lineage Tracing Reveals the Bipotency of SOX9+ Hepatocytes during Liver Regeneration

Ximeng Han, Yue Wang, Wenjuan Pu, +12

Stem Cell Reports

Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population

Ying Jing, Jinbo Hu, Rong Luo, +19

Annals of Internal Medicine

Hepatitis C Virus Core Protein Is a Potent Inhibitor of RNA Silencing-Based Antiviral Response

Yue Wang, Naoya Kato, Amarsanaa Jazag, +5

Gastroenterology

Potent InhibitorViral HepatitisImmunologyAntiviral Drug DevelopmentHepatitis +5